Rilonacept and Other Interleukin-1 Inhibitors in the Treatment of Recurrent Pericarditis.
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment, approximately 15-30% of patients with acute pericarditis have recurrence.
Aronow, Wilbert S +12 more
core +4 more sources
Pericarditis at the crossroads: Unlocking the next wave of therapies [PDF]
Pericarditis is an inflammation of the pericardial sac with different aetiologies. While often self-limited, up to 30 % of cases recur or become chronic, causing significant morbidity. Traditional treatments – nonsteroidal anti-inflammatory drugs (NSAIDs)
Massimo Imazio +5 more
doaj +2 more sources
Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap) [PDF]
Leigh D Church1, Sinisa Savic2, Michael F McDermott21Department of Rheumatology, Division of Immunity, Infection and Inflammation, Institute for Biomedical Research, The University of Birmingham, Birmingham, UK; 2Section of Musculoskeletal Disease, Leeds
Leigh D Church +2 more
doaj +2 more sources
Rilonacept and canakinumab [PDF]
Two new orphan medicines, rilonacept [1, 2] (Regeneron®) and canakinumab [3, 4] (Ilaris®), are indicated for the treatment of cryopyrin-associated periodic syndromes (CAPS). CAPS occur in a group of rare, inherited, inflammatory diseases where patients have a mutation in the NLRP3 (nucleotide-binding domain, leucine-rich family, pyrin domain-containing-
Eline A, Dubois +2 more
openaire +2 more sources
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis [PDF]
OBJECTIVE: Polypharmacy management of recurrent pericarditis (RP) often involves long-term therapies, often with negative effects. Slow tapering of oral therapies is often required to avoid recurrence.
Basil S Lewis +45 more
core +1 more source
Wirksamkeit und Sicherheit von Rilonacept in der Behandlung von Patientinnen und Patienten mit Kälteurtikaria [PDF]
Hintergrund und Zielsetzung Die Kälteurtikaria (KU) charakterisiert sich durch kälteinduzierte, juckende Quaddeln und wird gemäß der aktuellen Leitlinie mit nichtsedierenden Antihistaminika behandelt.
Spittler, Sebastian
core +1 more source
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
Objectives The objective of this systematic review was to assess the effects of interleukin-1β (IL-1β) inhibitors on gout flares. Methods Studies published between 2011 and 2022 that evaluated the effects of IL-1β inhibitors in adult patients ...
Naomi Schlesinger +3 more
doaj +1 more source
Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
Polygenic autoinflammatory diseases (AIDs), such as systemic juvenile idiopathic arthritis (sJIA), adult-onset Still's disease, Kawasaki disease, idiopathic recurrent pericarditis (IRP), Behçet’s Syndrome, Crystal-induced arthropatihes such as gout or ...
Hana Malcova +7 more
doaj +1 more source
Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review [PDF]
Objective: To conduct a bibliographic review on tuberculosis (TB) disease in children and adolescents with rheumatic diseases, being managed with biologic therapy. Data source: An integrative review with a search in the U.S. National Library of Medicine
Lenita de Melo Lima +5 more
doaj +1 more source
P154 Rilonacept use in lupus pericarditis
Luigi Adamo +2 more
doaj +2 more sources

